Global Community

ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.

US$163.75

23.6% undervalued

12.00%

Revenue growth p.a.

New

ING Groep

PittTheYounger

Community Contributor

ING leads the pack when it comes to pivoting towards non-lending income

The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.

€27.92

23.7% undervalued

9.00%

Revenue growth p.a.

New

Coles Group

Robbo

Community Contributor

Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap

AU$22.00

4.3% undervalued

8.72%

Revenue growth p.a.

New

Load previous narratives

Elevance Health

Key Takeaways Elevated costs in government-backed plans and greater reliance on value-based care could compress margins despite operational improvements and diversification strategies. Increasing regulatory changes, political uncertainty, and provider sophistication in technology may erode pricing power and add to earnings volatility.

Consensus Narrative from 18 Analysts

ACA And Medicaid Will Squeeze Margins Though Tech Will Aid

US$297.00

4.2% overvalued

6.18%

Revenue growth p.a.

7 days ago

Eli Lilly

Key Takeaways Potential drug pricing reforms and wider pricing parity efforts threaten future profitability and limit pricing power, especially for high-profile obesity and diabetes products. Heavy revenue reliance on a few core drugs and rising R&D demands increase vulnerability to competition, patent loss, and adverse data, risking future growth and margins.

Consensus Narrative from 26 Analysts

Drug Pricing Reforms And Patent Expiry Will Constrain Outcomes

US$650.00

7.9% overvalued

13.46%

Revenue growth p.a.

7 days ago

UnitedHealth Group

Key Takeaways Government scrutiny, regulatory interventions, and policy headwinds are likely to reduce margins and profitability across UnitedHealth's core business segments. Rising medical costs, intensifying competition, and operational challenges threaten revenue growth, expose structural weaknesses, and endanger long-term earnings potential.

Consensus Narrative from 23 Analysts

Medicare Scrutiny Will Deepen Margin Compression In Managed Care

US$198.00

53.5% overvalued

3.36%

Revenue growth p.a.

7 days ago

Oracle

Key Takeaways Reliance on legacy platforms and shifting customer preferences threaten core revenue streams, gross margins, and create heightened long-term volatility for future income. Intensifying competition and regulatory demands will increase compliance costs and further diminish Oracle's pricing power, scalability, and overall growth potential.

Consensus Narrative from 34 Analysts

Legacy Model Will Falter Amid Rising Compliance And Cloud Competition

US$175.00

41.9% overvalued

15.56%

Revenue growth p.a.

7 days ago

Costco Wholesale

Key Takeaways Evolving consumer behavior and urban demographics threaten Costco's bulk-sales model, risking slower same-store growth and long-term margin pressure. Rising costs and global expansion challenges could compress margins, while membership growth stagnates in mature markets, limiting future earnings potential.

Consensus Narrative from 30 Analysts

E-commerce And Urbanization Will Undermine Traditional Bulk Retailing

US$834.56

16.5% overvalued

4.93%

Revenue growth p.a.

7 days ago

Neogen Chemicals

Key Takeaways Expansion into lithium-ion battery materials and global supply diversification is driving strong growth opportunities in electric vehicle and renewable energy storage sectors. Strategic partnerships and rising custom manufacturing demand are enhancing technological capabilities, supporting sustainable margins and resilient earnings.

Consensus Narrative from 6 Analysts

Expanding Lithium Battery Materials Will Secure Global Reach

₹2.06k

32.1% undervalued

50.15%

Revenue growth p.a.

1 day ago

Ameresco

Key Takeaways Rising demand for advanced energy infrastructure and supportive government policies are driving Ameresco's pipeline growth, expanding margins, and improving revenue predictability. Increased recurring contract income, market diversification, and disciplined project selection enhance earnings stability, while investment in new technologies opens higher-margin opportunities.

Consensus Narrative from 9 Analysts

Increasing Demand And Government Incentives Will Drive Energy Expansion

US$25.78

16.9% undervalued

9.05%

Revenue growth p.a.

2 days ago

Unity Software

Key Takeaways Rapid innovation in AI-driven products and growing subscription business are driving sustained revenue growth, improved margins, and increased earnings stability. Expanding partnerships and broadening adoption across industries are diversifying revenue streams and strengthening Unity's long-term market position and competitive advantage.

Consensus Narrative from 22 Analysts

AI Developments And Partnerships With Tencent Will Expand Markets

US$31.67

20.0% overvalued

9.29%

Revenue growth p.a.

8 days ago

Forrester Research

Key Takeaways Growing focus on AI-driven research, digital transformation, and new frameworks drives stronger client engagement, subscription growth, and pricing power. Greater government contract wins, operational improvements, and longer client contracts support revenue diversification, stability, and improved future profit outlook.

Consensus Narrative from 1 Analyst

Generative AI Research Will Expand Opportunities Amid Challenges